Is $75.00 For Bausch & Lomb the FINAL Offer?

by Jon C. Ogg
24/7 Wall St.




Bausch & Lomb (BOL) has received a higher buyout price from Advanced Medical Optics (EYE) (or 'AMO' hereafter) in a cash and stock merger where Bausch & Lomb's shareholders would receive $45.00 in cash and roughly $30.00 in AMO stock, valued based on the average closing price of the AMO common stock for five trading days prior to the date a definitive agreement is signed.

The new proposal is subject to termination of Bausch & Lomb's previously announced merger agreement with Warburg Pincus and the execution of a definitive merger agreement with the company. The terms are subject to include that 'AMO' will have up to 12 months to close the transaction and that interest would be paid in cash with respect to the purchase price by 'AMO' at the rate of 7.2% per annum beginning six months after a definitive merger agreement is executed. BUT, the proposal is not subject to a financing condition and that may be an important kicker since there was a worry that this was too large of a bite for the company.


Continue article at 247WallSt.com




RELATED READING:
- Bausch & Lomb Selling Itself Away Too Cheap





24/7 Wall St. is a regular contributor to BioHealth Investor
_____________